Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/Benzoyl Peroxide Gel for Acne Vulgaris
NCT02515305Phase 3Completed
- Sponsor
- Padagis
- Start
- Jul 2015
- Primary completion
- Apr 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clindamycin and benzoyl peroxide + sulfur in acne vulgaris (3 arms), sponsored by Padagis. Primary endpoints: Mean Percent Change From Baseline in Inflammatory (Papules and Pustules) Lesions at Day 84 and Mean Percent Change From Baseline in Non-inflammatory (Open and Closed Comedones) Lesions at Day 84. Started Jul 2015; status: completed.
02
Drugs
clindamycinbenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02515305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515305.